$776 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 62 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TSRO | New | TESARO INC | $19,339,000 | – | 149,799 | +100.0% | 2.49% | – |
UNH | New | UNITEDHEALTH GRP INC | $19,233,000 | – | 98,205 | +100.0% | 2.48% | – |
GILD | New | GILEAD SCIENCES INC | $19,032,000 | – | 234,900 | +100.0% | 2.45% | – |
MOH | New | MOLINA HEALTHCARE | $15,152,000 | – | 220,359 | +100.0% | 1.95% | – |
ZLAB | New | ZAI LAB LTDadr | $7,171,000 | – | 265,600 | +100.0% | 0.92% | – |
EXAS | New | EXACT SCIENCES CORP | $5,539,000 | – | 117,550 | +100.0% | 0.71% | – |
VRTX | New | VERTEX PHARMACEUTICL | $5,169,000 | – | 34,000 | +100.0% | 0.67% | – |
New | INTEC PHARMA LTD JER | $3,177,000 | – | 355,000 | +100.0% | 0.41% | – | |
CMTA | New | CLEMENTIA PHARMACEUT | $512,000 | – | 30,313 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.